CongressInsight

Robert Aderholt Stock Trades: Disclosed Trades, Returns and Filing Delays

Every trade Robert Aderholt (U.S. House, Alabama’s 4th district) disclosed under the STOCK Act: what was bought and sold, how the stock purchases did against the S&P 500 and how long each disclosure took. Data as of Oct 20, 2026.

Published Updated 3 min readHow we research

Key takeaways

  • As of Oct 20, 2026, Robert Aderholt (U.S. House, Alabama’s 4th district) had disclosed 3 trades since Aug 26, 2022, 3 of them in individual stocks (1 buy, 2 sales).
  • Most‑traded stocks: GSK (1), TSLA (1), AAPL (1).
  • Robert Aderholt’s stock purchases trailed the S&P 500 by an average of 0.2 percentage points over the following 12 months (1 buy).
  • Every trade was disclosed within the STOCK Act’s 45‑day deadline; the median delay was 28 days.

How much does Robert Aderholt trade?

Robert Aderholt (U.S. House, Alabama’s 4th district) disclosed 3 trades between Aug 26, 2022 and Jul 28, 2025 in STOCK Act periodic transaction reports, 3 of them in individual stocks: 1 purchase and 2 sales. Their estimated volume is $24,002, from the midpoints of the disclosed ranges. By account owner: self or joint 67%, dependent child 33% of the trades.

MeasureRobert Aderholt
ChamberU.S. House, Alabama’s 4th district
Trades disclosed3
Stock trades3 (1 buy, 2 sales)
First and latest tradeAug 26, 2022 – Jul 28, 2025
Estimated volume$24,002
Account ownerSelf or joint 67% · Dependent child 33%

What stocks does Robert Aderholt trade?

StockCompanyTrades
GSK—1
TSLATesla, Inc.1
AAPLApple Inc.1

By sector: Other (1), Consumer Cyclical (1), Technology (1). Counts of disclosed trades in each stock, buys and sales together, before the last 30 days.

Has Robert Aderholt beaten the market?

Exent scored 1 disclosed stock purchase by Robert Aderholt against the S&P 500. Over the 12 months after each trade they trailed the S&P 500 by an average of 0.2 percentage points, and 0.0% of the 1 purchases that are a year old beat the index. Measured from the disclosure date, the first day the public could see each trade, the 12‑month figure was −1.6%. Robert Aderholt is not ranked: the ranking needs at least 20 purchases that are a year old.

MeasureRobert AderholtAll members
Stock buys scored124,613
Average vs S&P 500, 3 months−9.0%−0.1%
Average vs S&P 500, 12 months−0.2%−0.4%
Buys that beat it over 12 months0.0%43.2%
12 months from the disclosure date−1.6%−0.8%
RankNot ranked—

The 10 members with the best records by this measure are named in Exent Radar, with their latest trades.

Does Robert Aderholt file trades late?

All 3 of Robert Aderholt’s disclosed trades were reported within the STOCK Act’s 45‑day deadline; the median trade was disclosed 28 days after it was made.

MeasureRobert AderholtAll members
Median days to disclose28 days28 days
Disclosed after 45 days0.0%14.9%
Longest delay45 days—

Robert Aderholt’s latest disclosed trades

Trades disclosed before Sep 20, 2026 are listed below, newest first, each with a link to the original filing.

Trade dateStockTradeAmountDisclosed after
Jul 28, 2025GSKSale$1,001–$15,00045 days · filing
Dec 5, 2022TSLASale (dependent child)$1,001–$15,0008 days · filing
Aug 26, 2022AAPLBuy$1,001–$15,00028 days · filing
Trade dateJul 28, 2025Dec 5, 2022Aug 26, 2022
StockGSKTSLAAAPL
TradeSaleSale (dependent child)Buy
Amount$1,001–$15,000$1,001–$15,000$1,001–$15,000
Disclosed after45 days · filing8 days · filing28 days · filing

Where this data comes from

Members of Congress report each trade over $1,000 in stocks, bonds and other securities, by themselves, their spouse or dependent children, in periodic transaction reports under the STOCK Act, filed with the House Clerk and the Senate. A trade must be reported within 45 days. Exent reads these public financial disclosures; every trade listed here links to its original filing.

Amounts are disclosed as ranges ($1,001–$15,000, $15,001–$50,000 and up), so dollar volumes are estimates from the midpoint of each range. Returns compare each disclosed purchase of a listed stock with the S&P 500 (SPY): total return with dividends from the close on the trade date to 3 and 12 months later, and again from the disclosure date, the first day the public could see the trade. Sales are not scored. The ranking covers members with at least 20 purchases that are a year old.

Trades disclosed in the last 30 days are counted but not listed; they are in Exent Radar, with the records of the top 10 performers. The disclosures carry no party labels: this is the public record of what was traded and when it was disclosed. Data as of Oct 20, 2026. How to read a filing yourself: Congress stock trading: how to see what members bought.

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow Congress trades as they are disclosed

  1. Exent Radar lists new congressional trades as they are disclosed, before they reach this page.
  2. It names the top 10 members by the record of their stock buys, next to insider buying and big‑fund moves.
  3. Check any idea against your own portfolio before you act on it.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

In STOCK Act disclosures, the stocks Robert Aderholt traded most often are GSK (1 trade), TSLA (1 trade), AAPL (1 trade). Of 3 disclosed trades, 3 were in individual stocks. Periodic transaction reports show trades, not full holdings.

Robert Aderholt's disclosed stock purchases trailed the S&P 500 by an average of 0.2 percentage points over the 12 months after each trade (1 purchases a year old), and 0.0% of them beat the index. Measured from the disclosure date the average was −1.6%. Past results do not predict future ones.

No: all 3 disclosed trades were reported within the STOCK Act's 45-day deadline. The median trade was disclosed 28 days after it was made; across Congress the median is 28 days.

See the latest Congress trades in Radar

Exent Radar shows trades by members of Congress, company insiders and big funds as they are disclosed, with the records of the top performers.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.